Tox | Related Drugs | BioActivity |

Stem definition	Drug id	CAS RN
	470	76-22-2

Description:

Molecule	Description
Molfile Inchi Smiles Synonyms: camphor alphanon borneo camphor DL-Camphor root bark oil 2-Bornanone 2-Camphanone camphor (synthetic) camphor (natural) camphor, (synthetic) camphor, (+/-)- camphora	A bicyclic monoterpene ketone found widely in plants, especially CINNAMOMUM CAMPHORA. It is used topically as a skin antipruritic and as an anti-infective agent. Molecular weight: 152.24 Formula: C10H16O CLOGP: 2.18 LIPINSKI: 0 HAC: 1 HDO: 0 TPSA: 17.07 ALOGS: -2.24 ROTB: 0

Molecule

Description

Molfile Inchi Smiles

Synonyms:

camphor
alphanon
borneo camphor
DL-Camphor
root bark oil
2-Bornanone
2-Camphanone
camphor (synthetic)
camphor (natural)
camphor, (synthetic)
camphor, (+/-)-
camphora

A bicyclic monoterpene ketone found widely in plants, especially CINNAMOMUM CAMPHORA. It is used topically as a skin antipruritic and as an anti-infective agent.

Molecular weight: 152.24
Formula: C10H16O
CLOGP: 2.18
LIPINSKI: 0
HAC: 1
HDO: 0
TPSA: 17.07
ALOGS: -2.24
ROTB: 0

Drug dosage:

Dose	Unit	Route
0.15	g	O

ADMET properties:

None

Predicted pharmacokinetic/toxicological properties (PK-AZ):

Property	Description	Value
kinase-safety-class	ACVR2A,ACVR2B,AURKA,AXL,BRAF,BTK,CAMK2B,CAMK2D,CDK5,CDK9,DDR1,DYRK1B,EIF2AK3,EPHB4,ERBB2,FLT3,GRK2,GSK3B,ITK,JAK2,MAP3K21,MAP3K7,MAPK10,MAPK7,MAPKAPK2,NTRK2,PDK1,PDK2,PDK4,PDPK1,PIK3CB,PIK3CG,PIM2,PRKDC,SIK2,SIK3,STK33,SYK,TEK,TTK	40
kinase-selectivity-class	EIF2AK3,GRK2,PDK2	3
pfas-class	PFAS structural alert (1 = True, 0 = False)	0

Approvals:

Date	Agency	Company	Orphan
None	FDA

FDA Adverse Event Reporting System (Female)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Joint dislocation	152.13	14.82	104	19722	44478	90564143
Seronegative arthritis	137.52	14.82	71	19755	18163	90590458
Methaemoglobinaemia	137.02	14.82	46	19780	3969	90604652
Prescribed underdose	117.82	14.82	111	19715	74908	90533713
Joint stiffness	110.36	14.82	109	19717	77933	90530688
Lupus vulgaris	93.32	14.82	78	19748	44981	90563640
Walking aid user	89.57	14.82	69	19757	35437	90573184
Wound infection	89.01	14.82	113	19713	106289	90502332
Retinitis	88.95	14.82	71	19755	38387	90570234
Laryngitis	87.24	14.82	79	19747	50674	90557947
Lupus-like syndrome	83.89	14.82	76	19750	48770	90559851
Type 2 diabetes mellitus	83.33	14.82	155	19671	203089	90405532
Upper respiratory tract infection	82.62	14.82	120	19706	128198	90480423
Hypercholesterolaemia	81.01	14.82	105	19721	100787	90507834
Osteoporosis	79.92	14.82	102	19724	96429	90512192
Sciatica	79.06	14.82	104	19722	101278	90507343
Visual impairment	76.94	14.82	118	19708	132247	90476374
Road traffic accident	74.20	14.82	104	19722	107522	90501099
Adjustment disorder with depressed mood	72.41	14.82	75	19751	56678	90551943
Autoimmune disorder	63.37	14.82	81	19745	76663	90531958
Osteoarthritis	63.06	14.82	135	19691	195595	90413026
Broncholithiasis	60.83	14.82	14	19812	293	90608328
Lymph node calcification	57.50	14.82	14	19812	376	90608245
Joint range of motion decreased	56.24	14.82	104	19722	135539	90473082
Anti-cyclic citrullinated peptide antibody	56.10	14.82	47	19779	27174	90581447
Prescribed overdose	55.26	14.82	86	19740	97539	90511082
Psoriasis	53.55	14.82	107	19719	147647	90460974
Hepatic cirrhosis	51.02	14.82	66	19760	63187	90545434
Exostosis	50.16	14.82	60	19766	53074	90555547
Lower limb fracture	49.67	14.82	76	19750	84937	90523684
Urticaria thermal	48.40	14.82	13	19813	520	90608101
Liver function test increased	48.37	14.82	75	19751	84780	90523841
Hip arthroplasty	47.18	14.82	70	19756	76138	90532483
Disability	46.92	14.82	51	19775	40694	90567927
Urticaria	46.28	14.82	162	19664	312572	90296049
Foot deformity	46.18	14.82	61	19765	59590	90549031
Bone erosion	45.40	14.82	57	19769	52964	90555657
Dislocation of vertebra	44.51	14.82	58	19768	55910	90552711
Amnesia	43.48	14.82	82	19744	108423	90500198
Spinal fusion surgery	42.69	14.82	29	19797	12254	90596367
Deep vein thrombosis postoperative	42.35	14.82	64	19762	70745	90537876
Red blood cell sedimentation rate increased	41.59	14.82	69	19757	82526	90526095
Pulmonary fibrosis	41.54	14.82	80	19746	107423	90501198
Spondylitis	41.20	14.82	30	19796	14148	90594473
Swollen joint count increased	40.84	14.82	81	19745	111125	90497496
Knee arthroplasty	38.59	14.82	67	19759	83115	90525506
Grip strength decreased	38.38	14.82	71	19755	92505	90516116
Administration site erythema	37.40	14.82	12	19814	897	90607724
Irritable bowel syndrome	36.51	14.82	114	19712	207334	90401287
Ear infection	36.08	14.82	59	19767	69716	90538905
Mobility decreased	34.61	14.82	127	19699	250607	90358014
Bronchial wall thickening	34.10	14.82	14	19812	2117	90606504
Delirium	33.59	14.82	72	19754	104287	90504334
Fibromyalgia	33.25	14.82	110	19716	206159	90402462
Wheezing	32.36	14.82	120	19706	237960	90370661
Lichen nitidus	32.01	14.82	7	19819	115	90608506
Blood cholesterol increased	31.82	14.82	109	19717	207903	90400718
Breast cancer stage III	31.59	14.82	62	19764	84385	90524236
Oedema	31.56	14.82	106	19720	200189	90408432
Gait inability	30.04	14.82	85	19741	146371	90462250
Hypoaesthesia	29.17	14.82	141	19685	314069	90294552
Tachycardia	28.99	14.82	88	19738	157585	90451036
Asthma	28.78	14.82	117	19709	242043	90366578
Contusion	28.78	14.82	120	19706	251096	90357525
Injury	28.10	14.82	101	19725	197248	90411373
Drug ineffective	28.02	14.82	183	19643	1384115	89224506
Muscular weakness	27.11	14.82	103	19723	206563	90402058
C-reactive protein increased	26.82	14.82	94	19732	181295	90427326
Rheumatic fever	26.79	14.82	84	19742	153037	90455584
Liver injury	26.63	14.82	90	19736	170477	90438144
Pigmentation disorder	25.45	14.82	16	19810	5933	90602688
Drug-induced liver injury	25.34	14.82	59	19767	90259	90518362
Nail bed tenderness	24.15	14.82	7	19819	371	90608250
Wound	21.96	14.82	127	19699	302853	90305768
Electrocardiogram PR shortened	21.68	14.82	7	19819	534	90608087
Oedema peripheral	20.61	14.82	111	19715	257804	90350817
Scratch	20.25	14.82	17	19809	9849	90598772
Helicobacter infection	19.06	14.82	99	19727	226751	90381870
Weight decreased	18.91	14.82	145	19681	379765	90228856
Psoriatic arthropathy	18.74	14.82	99	19727	228236	90380385
Sinusitis	18.23	14.82	133	19693	342955	90265666
Rheumatoid factor positive	18.10	14.82	80	19746	171570	90437051
Nasopharyngitis	17.88	14.82	151	19675	406953	90201668
Vitamin B12 deficiency	17.68	14.82	14	19812	7472	90601149
Cerebrovascular accident	17.44	14.82	3	19823	123530	90485091
Dizziness postural	17.36	14.82	15	19811	9038	90599583
Sexual abuse	17.33	14.82	5	19821	261	90608360
Disinhibition	17.03	14.82	7	19819	1061	90607560
Muscle injury	16.90	14.82	80	19746	176574	90432047
Weight increased	16.79	14.82	152	19674	417775	90190846
Neutropenia	16.41	14.82	15	19811	224889	90383732
Hypotension	16.19	14.82	29	19797	325368	90283253
Disease progression	16.16	14.82	7	19819	156608	90452013
Pruritus	15.59	14.82	184	19642	541341	90067280
Contraindicated product administered	15.51	14.82	29	19797	320110	90288511
Soft tissue necrosis	15.38	14.82	6	19820	794	90607827
Autonomic neuropathy	15.08	14.82	7	19819	1420	90607201
Impaired healing	14.94	14.82	95	19731	234104	90374517

FDA Adverse Event Reporting System (Male)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Methaemoglobinaemia	157.14	17.86	45	3739	5729	42611822
Choroiditis	67.08	17.86	17	3767	1358	42616193
Endophthalmitis	59.01	17.86	20	3764	4413	42613138
Visual acuity reduced	40.54	17.86	23	3761	17527	42600024
Intraocular pressure increased	37.93	17.86	16	3768	6417	42611134
Completed suicide	33.50	17.86	42	3742	96423	42521128
Pruritus	32.25	17.86	59	3725	188712	42428839
Eye pain	30.64	17.86	19	3765	17011	42600540
Condition aggravated	28.69	17.86	68	3716	260686	42356865
Haemolysis	26.07	17.86	14	3770	9575	42607976
Anticholinergic syndrome	24.45	17.86	8	3776	1581	42615970
Chondritis	23.27	17.86	5	3779	193	42617358
Skin infection	20.86	17.86	12	3772	9368	42608183
Erythema multiforme	20.18	17.86	12	3772	9965	42607586
Cellulitis	20.06	17.86	26	3758	61559	42555992
Post inflammatory pigmentation change	18.75	17.86	5	3779	487	42617064
Dermatitis exfoliative	18.49	17.86	10	3774	6937	42610614

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Methaemoglobinaemia	291.34	13.25	88	14401	9080	110565730
Broncholithiasis	62.81	13.25	13	14476	279	110574531
Lymph node calcification	56.68	13.25	13	14476	456	110574354
Urticaria thermal	55.07	13.25	13	14476	518	110574292
Choroiditis	53.43	13.25	16	14473	1599	110573211
Administration site erythema	52.15	13.25	12	14477	427	110574383
Pruritus	39.74	13.25	166	14323	581394	109993416
Endophthalmitis	36.70	13.25	19	14470	8168	110566642
Lichen nitidus	34.06	13.25	7	14482	145	110574665
Scratch	33.50	13.25	21	14468	12958	110561852
Bronchial wall thickening	32.04	13.25	13	14476	3194	110571616
Completed suicide	30.54	13.25	85	14404	242296	110332514
Sciatica	30.27	13.25	48	14441	92351	110482459
Pigmentation disorder	30.02	13.25	16	14473	7295	110567515
Adjustment disorder with depressed mood	28.71	13.25	32	14457	43851	110530959
Autoimmune disorder	28.67	13.25	39	14450	65444	110509366
Soft tissue necrosis	27.60	13.25	9	14480	1189	110573621
Nail bed tenderness	27.60	13.25	7	14482	377	110574433
Road traffic accident	26.25	13.25	49	14440	107349	110467461
Contusion	24.77	13.25	77	14412	233284	110341526
Intraocular pressure increased	24.13	13.25	16	14473	10860	110563950
Asthma	22.45	13.25	78	14411	250213	110324597
Psoriasis	21.62	13.25	53	14436	139940	110434870
Vitamin B12 deficiency	20.41	13.25	14	14475	10041	110564769
Visual acuity reduced	20.25	13.25	23	14466	32150	110542660
Dizziness postural	19.90	13.25	16	14473	14593	110560217
Sleep disorder due to general medical condition, insomnia type	18.49	13.25	42	14447	105601	110469209
Cyanosis	18.28	13.25	21	14468	29720	110545090
Skin plaque	17.54	13.25	14	14475	12631	110562179
Nasal congestion	17.12	13.25	39	14450	98243	110476567
Haemolysis	16.92	13.25	15	14474	15624	110559186
Adverse event	16.59	13.25	41	14448	108768	110466042
Lip swelling	16.15	13.25	26	14463	50641	110524169
Vulvovaginal swelling	15.74	13.25	5	14484	608	110574202
Oropharyngeal discomfort	15.55	13.25	12	14477	10315	110564495
Secretion discharge	15.41	13.25	16	14473	20228	110554582
Skin discolouration	15.40	13.25	25	14464	49021	110525789
Autonomic neuropathy	15.32	13.25	7	14482	2293	110572517
Chondritis	15.11	13.25	4	14485	255	110574555
Eye pain	15.01	13.25	25	14464	50074	110524736
Seronegative arthritis	14.98	13.25	13	14476	13164	110561646
Type 2 diabetes mellitus	14.83	13.25	54	14435	177178	110397632
Post inflammatory pigmentation change	14.57	13.25	5	14484	772	110574038
Skin infection	14.01	13.25	16	14473	22493	110552317
Toxicity to various agents	13.86	13.25	109	14380	480446	110094364
Anticholinergic syndrome	13.83	13.25	8	14481	4272	110570538

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Source	Code	Description
ATC	C01EB02	CARDIOVASCULAR SYSTEM CARDIAC THERAPY OTHER CARDIAC PREPARATIONS Other cardiac preparations
MeSH PA	D000890	Anti-Infective Agents
MeSH PA	D000891	Anti-Infective Agents, Local
CHEBI has role	CHEBI:35480	analgesic
CHEBI has role	CHEBI:35554	cardiovascular drug
CHEBI has role	CHEBI:51177	antitussive
CHEBI has role	CHEBI:64952	anti-HSV agent
CHEBI has role	CHEBI:67079	anti-inflammatory agent
CHEBI has role	CHEBI:76924	plant metabolite
CHEBI has role	CHEBI:77715	nasal decongestant

Related Drugs by ATC class:

C01EB Other cardiac preparations 15 drugs

acadesine acoramidis adenosine creatinolfosfate ibuprofen indomethacin ivabradine mavacamten meldonium phosphocreatine ranolazine regadenoson show all 15 →

Drug Use | Suggest Off label Use Form| |View source of the data|

Disease	Relation	SNOMED_ID	DOID
Backache	indication	161891005
Sprains and Strains	indication
Arthritic Pain	indication
Gastritis	contraindication	4556007	DOID:4029
Infection of skin AND/OR subcutaneous tissue	contraindication	19824006
Gastrointestinal ulcer	contraindication	40845000
Body fluid retention	contraindication	43498006
Disorder of cardiovascular system	contraindication	49601007	DOID:1287
Vitamin K deficiency	contraindication	52675005	DOID:11249
Nasal polyp	contraindication	52756005
Hepatic failure	contraindication	59927004
Blood coagulation disorder	contraindication	64779008	DOID:1247
Diabetes mellitus	contraindication	73211009	DOID:9351
Factor II deficiency	contraindication	73975000
Gastrointestinal hemorrhage	contraindication	74474003
Thrombotic thrombocytopenic purpura	contraindication	78129009	DOID:10772
Kidney disease	contraindication	90708001	DOID:557
Thyrotoxicosis	contraindication	90739004	DOID:7997
Hemophilia	contraindication	90935002
Disorder of skin	contraindication	95320005	DOID:37
Anemia due to enzyme deficiency	contraindication	111577008
Gastroesophageal reflux disease	contraindication	235595009	DOID:8534
Disease of liver	contraindication	235856003	DOID:409
Condyloma acuminatum	contraindication	240542006	DOID:11168
Anemia	contraindication	271737000	DOID:2355
Pregnancy, function	contraindication	289908002
Skin irritation	contraindication	367466007
Cardiovascular event risk	contraindication	395112001
Peripheral vascular disease	contraindication	400047006
Breastfeeding (mother)	contraindication	413712001
Blister	contraindication	417237009
Denuded skin	contraindication	418242004
Inflammatory dermatosis	contraindication	703938007

🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

Target	Class	Pharos	UniProt	Action	Type	Activity value (-log[M])	Mechanism action	Bioact source	MoA source
Acetylcholinesterase	Enzyme		ACES_ELEEL		Ki	4.30		CHEMBL
Transient receptor potential cation channel subfamily A member 1	Ion channel		TRPA1_MOUSE	GATING INHIBITOR	IC50	4.20		IUPHAR

External reference:

ID	Source
4017533	VUID
N0000145916	NUI
D00098	KEGG_DRUG
464-49-3	SECONDARY_CAS_RN
1298738	RXNORM
C0006809	UMLSCUI
CHEBI:15396	CHEBI
CAM	PDB_CHEM_ID
CHEMBL15768	ChEMBL_ID
DB01744	DRUGBANK_ID
D002164	MESH_DESCRIPTOR_UI
2537	PUBCHEM_CID
2422	IUPHAR_LIGAND_ID
DB11288	DRUGBANK_ID
DB14156	DRUGBANK_ID
4343	MMSL
6005	MMSL
111136003	SNOMEDCT_US
412108007	SNOMEDCT_US
46137002	SNOMEDCT_US
4017533	VANDF
C436264	MESH_SUPPLEMENTAL_RECORD_UI
5TJD82A1ET	UNII
001385	NDDF
001993	NDDF
005178	NDDF
006104	NDDF
5TJD82A1ET	INXIGHT DRUGS

Pharmaceutical products:

Product	Category	Ingredients	NDC	Form	Quantity	Route	Marketing	Label
AleveX	HUMAN OTC DRUG LABEL	2	0280-0049	SPRAY	5.50 mg	TOPICAL	OTC Monograph Drug	15 sections
AleveX	HUMAN OTC DRUG LABEL	2	0280-0050	LOTION	5.50 mg	TOPICAL	OTC Monograph Drug	15 sections
AleveX	HUMAN OTC DRUG LABEL	2	0280-0063	LOTION	5.50 mg	TOPICAL	OTC Monograph Drug	14 sections
Sarna	HUMAN OTC DRUG LABEL	2	0316-0229	LOTION	5 mg	TOPICAL	OTC Monograph Drug	14 sections
Vaporizing	HUMAN OTC DRUG LABEL	1	0363-0055	INHALANT	62 mg	RESPIRATORY (INHALATION)	OTC Monograph Drug	15 sections
WALGREENS MEDICATED PAIN RELIEVING	HUMAN OTC DRUG LABEL	3	0363-0149	PATCH	7.10 mg	TOPICAL	OTC monograph not final	14 sections
Walgreens Cold Sore Treatment	HUMAN OTC DRUG LABEL	2	0363-0407	CREAM	30 mg	TOPICAL	OTC monograph not final	10 sections
Walgreens Cold Sore Treatment	HUMAN OTC DRUG LABEL	2	0363-0407	CREAM	30 mg	TOPICAL	OTC monograph not final	10 sections
Pain Relief Patches	HUMAN OTC DRUG LABEL	3	0363-0907	PATCH	3.10 g	TOPICAL	OTC Monograph Drug	11 sections
Walgreens Chest Rub	HUMAN OTC DRUG LABEL	3	0363-1001	OINTMENT	48 mg	TOPICAL	OTC Monograph Drug	12 sections
Walgreens Chest Rub	HUMAN OTC DRUG LABEL	3	0363-1004	OINTMENT	48 mg	TOPICAL	OTC Monograph Drug	12 sections
Walgreens Pain RelievingAnalgesic	HUMAN OTC DRUG LABEL	3	0363-1199	CREAM	40 mg	TOPICAL	OTC Monograph Drug	15 sections
No Touch Application Chest RubWell at Walgreens	HUMAN OTC DRUG LABEL	3	0363-3267	STICK	4.80 g	TOPICAL	OTC monograph final	7 sections
Walgreen Anti Itch	HUMAN OTC DRUG LABEL	2	0363-4262	LOTION	0.50 g	TOPICAL	OTC Monograph Drug	12 sections
Medicated Lip Balm	HUMAN OTC DRUG LABEL	3	0363-6040	SALVE	1.70 mg	TOPICAL	OTC monograph not final	9 sections
Medicated Lip Balm	HUMAN OTC DRUG LABEL	3	0363-6080	STICK	1.70 mg	TOPICAL	OTC monograph not final	9 sections
Walgreens Pain Relieving Patch	HUMAN OTC DRUG LABEL	3	0363-6716	PATCH	31 mg	TOPICAL	OTC Monograph Drug	13 sections
Chest Rub	HUMAN OTC DRUG LABEL	3	0363-8480	LOTION	4.80 kg	TOPICAL	OTC monograph final	15 sections
Walgreens Camphor Phenol Gel	HUMAN OTC DRUG LABEL	2	0363-9425	GEL	10.80 mg	TOPICAL	OTC monograph not final	8 sections
Walgreens Childrens Chest Rub	HUMAN OTC DRUG LABEL	3	0363-9800	OINTMENT	48 mg	TOPICAL	OTC Monograph Drug	12 sections
Walgreens Lavender Chest Rub	HUMAN OTC DRUG LABEL	3	0363-9802	OINTMENT	47 mg	TOPICAL	OTC Monograph Drug	15 sections
Pain Relieving Patches	HUMAN OTC DRUG LABEL	3	0363-9903	PATCH	1.20 g	TOPICAL	OTC Monograph Drug	12 sections
Large Pain Relieving	HUMAN OTC DRUG LABEL	3	0363-9904	PATCH	3.10 g	TOPICAL	OTC Monograph Drug	13 sections
HUMCO Camphor Spirit	HUMAN OTC DRUG LABEL	1	0395-0467	LIQUID	100 mg	TOPICAL	OTC Monograph Drug	13 sections
Camphor Spirit	HUMAN OTC DRUG LABEL	1	0395-9112	LIQUID	100 mg	TOPICAL	OTC monograph not final	12 sections
Rugby Anti-Itch	HUMAN OTC DRUG LABEL	2	0536-1268	LOTION	0.50 g	TOPICAL	OTC Monograph Drug	11 sections
ANBESOL COLD SORE THERAPY	HUMAN OTC DRUG LABEL	4	0573-0246	OINTMENT	30 mg	TOPICAL	OTC monograph not final	14 sections
CHAPSTICK MEDICATED	HUMAN OTC DRUG LABEL	4	0573-0720	STICK	10 mg	TOPICAL	OTC Monograph Drug	13 sections
CHAPSTICK CLASSIC MEDICATED	HUMAN OTC DRUG LABEL	3	0573-2031	STICK	16 mg	TOPICAL	OTC Monograph Drug	13 sections
Advil Targeted Relief	HUMAN OTC DRUG LABEL	4	0573-6555	CREAM	31 mg	TOPICAL	OTC Monograph Drug	16 sections

Ask DrugCentral

Try a sample question

camphor 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Description:

Drug dosage:

ADMET properties:

Predicted pharmacokinetic/toxicological properties (PK-AZ):

Approvals:

FDA Adverse Event Reporting System (Female)

FDA Adverse Event Reporting System (Male)

FDA Adverse Event Reporting System (Geriatric)

FDA Adverse Event Reporting System (Pediatric)

Pharmacologic Action:

Related Drugs by ATC class:

Drug Use | Suggest Off label Use Form| |View source of the data|

🐶 Veterinary Drug Use

🐶 Veterinary products

Acid dissociation constants calculated using MoKa v3.0.0

Orange Book patent data (new drug applications)

Orange Book exclusivity data (new drug applications)

Bioactivity Summary:

External reference:

Pharmaceutical products: